House of Lords Revisits ‘Biogen’ Insufficiency; Novartis' Fluvastatin Patent Obvious; High Court Finds Patent for Slow Release Formulation Valid but not Infringed

Authors :: James Armstrong
Rebecca Singleton
Jade MacIntyre
Michael Burdon
Source :: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 6:264-271
Publication Year :: 2009
Publisher :: SAGE Publications, 2009.

Subjects :: business.industry
Law
Slow Release Formulation
Pharmaceutical Science
Medicine
High Court
business
Fluvastatin
medicine.drug

ISSN :: 17417090 and 17411343
Volume :: 6
Database :: OpenAIRE
Journal :: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
Accession number :: edsair.doi...........1830d76c05b7b8fb00640d8e915dfd5a

Tools